CHMP5 and COVID-19: The plasma antigen data for SARS-CoV-2 nucleocapsid (N) and spike (S) proteins were available for 304 participants who were positive for COVID-19, who were similar in demographic profiles as the entire cohort (Supplemental Table 3), and for 20 negative controls.